Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
about
Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Ladarixin, a dual CXCR1/2 inhi ...... ls and tumor microenvironment.
@en
type
label
Ladarixin, a dual CXCR1/2 inhi ...... ls and tumor microenvironment.
@en
prefLabel
Ladarixin, a dual CXCR1/2 inhi ...... ls and tumor microenvironment.
@en
P2093
P2860
P356
P1433
P1476
Ladarixin, a dual CXCR1/2 inhi ...... ls and tumor microenvironment.
@en
P2093
Alyson Pidich
Daria Marley Kemp
Elizabeth Lash
Marcello Allegretti
Maria De Pizzol
Mary Larijani
Mizue Terai
Olga Igoucheva
Rebecca Jonas
Takami Sato
P2860
P304
14428-14442
P356
10.18632/ONCOTARGET.14803
P407
P577
2017-01-24T00:00:00Z